News
The PD-L1 Inhibitors drugs uptake section examines the rate at which newly launched or upcoming potential drugs are being ...
The firm will assess irpagratinib plus best supportive care in patients with FGF19-overexpressing advanced liver cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback